New tRNA tech aims to rewrite rare disease treatment
Drug Target Review
JUNE 9, 2025
One company leading the charge in this revolution is Alltrna , whose pioneering work in engineered transfer RNA (tRNA) therapeutics is offering new hope for patients with rare genetic diseases. we are first focused on engineering tRNAs to restore protein production in diseases caused by premature termination codons.
Let's personalize your content